ALL | opacc

To wipe childhood cancer off the map, scientists must chart its genomic landscape

Scientists have created a roadmap of the genetic mutations present in the most common childhood cancer, acute lymphoblastic leukemia...

Protein activity reveals new childhood ALL combination treatment strategy

Blocking a protein chain reaction makes childhood leukemia cells more sensitive to an existing targeted treatment, a new study shows....

Inherited gene variant powers up an oncogene to drive a high-risk leukemia

Scientists at St. Jude Children’s Research Hospital have revealed how an inherited genetic variant turns on an oncogene, increasing...

Genetic ancestry provides important context for understanding global diversity in childhood leukemia

St. Jude Children's Research Hospital scientists have shown that addressing racial disparities in acute lymphoblastic leukemia should...

Study Confirms Nutrient’s Role in Childhood Blood Cancer

A molecular building block of many animal proteins, the amino acid valine, plays a key role in cancerous growth seen in T cell acute...

Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia

Despite major advances in the treatment of acute lymphoblastic leukemia (ALL), adult survivors face long-term health consequences. A ...

USC study identifies new risk factor for most common childhood cancer, Acute Lymphoblastic Leukemia

According the research, children genetically predisposed to overproduce lymphocytes in relation to other white blood cells are at...

Pediatric ALL Relapse May Be Caused by Mutations From Chemotherapy

Chemotherapy is standard care for pediatric acute lymphoblastic leukemia (ALL), but new research shows thiopurines can cause mutations ...

International Collaboration Helps Refine Treatment for Childhood Leukemia

Scientists at St. Jude Children’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute...

FDA Approves Rylaze as Alternative for Patients with ALL and Lymphoblastic Lymphoma

New FDA approval means that pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lympoblastic lymphoma who are...

1

To wipe childhood cancer off the map, scientists must chart its genomic landscape

Childhood Liver Cancer "Signatures" May Help Predict Response to Chemo

New chemical technology leads to better targeted therapeutics against high-risk leukemia in the lab

Hopes of a new curative treatment for children with neuroblastoma

Scientists are a step closer to finding a low toxicity treatment for childhood leukaemia

Researchers identify an Achilles’ heel in neuroblastoma

To save children with cancer, doctors turn to new weapons

Childhood Cancer Survivors Are at an Increased Risk for Hospitalization Years After Treatment Ends

Novel targeted therapy could be effective treatment option for deadly childhood cancer

Gene That Causes Deadliest Brain Tumor Also Causes Childhood Cancer